Pedraza-Chaverri José, Sánchez-Lozada Laura G, Osorio-Alonso Horacio, Tapia Edilia, Scholze Alexandra
Department of Biology, Faculty of Chemistry, UNAM, 04510 Mexico City, DF, Mexico.
Laboratory of Renal Physiopathology, INC Ignacio Chávez, 14080 Mexico City, DF, Mexico; Department of Nephrology, INC Ignacio Chávez, 14080 Mexico City, DF, Mexico.
Oxid Med Cell Longev. 2016;2016:6043601. doi: 10.1155/2016/6043601. Epub 2016 Jun 27.
In chronic kidney disease inflammatory processes and stimulation of immune cells result in overproduction of free radicals. In combination with a reduced antioxidant capacity this causes oxidative stress. This review focuses on current pathogenic concepts of oxidative stress for the decline of kidney function and development of cardiovascular complications. We discuss the impact of mitochondrial alterations and dysfunction, a pathogenic role for hyperuricemia, and disturbances of vitamin D metabolism and signal transduction. Recent antioxidant therapy options including the use of vitamin D and pharmacologic therapies for hyperuricemia are discussed. Finally, we review some new therapy options in diabetic nephropathy including antidiabetic agents (noninsulin dependent), plant antioxidants, and food components as alternative antioxidant therapies.
在慢性肾脏病中,炎症过程和免疫细胞的刺激导致自由基产生过多。再加上抗氧化能力降低,这就会引发氧化应激。本综述聚焦于氧化应激在肾功能下降和心血管并发症发生中的当前致病概念。我们讨论了线粒体改变和功能障碍的影响、高尿酸血症的致病作用以及维生素D代谢和信号转导的紊乱。还讨论了近期的抗氧化治疗选择,包括使用维生素D和针对高尿酸血症的药物治疗。最后,我们综述了糖尿病肾病中的一些新治疗选择,包括抗糖尿病药物(非胰岛素依赖型)、植物抗氧化剂和食物成分作为替代抗氧化疗法。